Global Antiretroviral Drug Market Growth (Status and Outlook) 2022-2028
- LP 4819549
- 86 Pages
- February 2022
- Pharmaceuticals
The United States Antiretroviral Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Antiretroviral Drug market, reaching US$ million by the year 2028. As for the Europe Antiretroviral Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Antiretroviral Drug players cover Gilead Sciences, ViiV Healthcare, Bristol-Myer Squibb, and AbbVie, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Antiretroviral Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Multi-Class Drugs Combination
NRTI
NNRTI
Protease Inhibitors
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Pharmaceutical Companies
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Gilead Sciences
ViiV Healthcare
Bristol-Myer Squibb
AbbVie
Boehringer-Ingelheim
Johnson and Johnson
Merck
CIPLA
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antiretroviral Drug Market Size 2017-2028
2.1.2 Antiretroviral Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Antiretroviral Drug Segment by Type
2.2.1 Multi-Class Drugs Combination
2.2.2 NRTI
2.2.3 NNRTI
2.2.4 Protease Inhibitors
2.2.5 Other
2.3 Antiretroviral Drug Market Size by Type
2.3.1 Antiretroviral Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Antiretroviral Drug Market Size Market Share by Type (2017-2022)
2.4 Antiretroviral Drug Segment by Application
2.4.1 Hospital
2.4.2 Pharmaceutical Companies
2.4.3 Other
2.5 Antiretroviral Drug Market Size by Application
2.5.1 Antiretroviral Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Antiretroviral Drug Market Size Market Share by Application (2017-2022)
3 Antiretroviral Drug Market Size by Player
3.1 Antiretroviral Drug Market Size Market Share by Players
3.1.1 Global Antiretroviral Drug Revenue by Players (2020-2022)
3.1.2 Global Antiretroviral Drug Revenue Market Share by Players (2020-2022)
3.2 Global Antiretroviral Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Antiretroviral Drug by Regions
4.1 Antiretroviral Drug Market Size by Regions (2017-2022)
4.2 Americas Antiretroviral Drug Market Size Growth (2017-2022)
4.3 APAC Antiretroviral Drug Market Size Growth (2017-2022)
4.4 Europe Antiretroviral Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Antiretroviral Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Antiretroviral Drug Market Size by Country (2017-2022)
5.2 Americas Antiretroviral Drug Market Size by Type (2017-2022)
5.3 Americas Antiretroviral Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antiretroviral Drug Market Size by Region (2017-2022)
6.2 APAC Antiretroviral Drug Market Size by Type (2017-2022)
6.3 APAC Antiretroviral Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Antiretroviral Drug by Country (2017-2022)
7.2 Europe Antiretroviral Drug Market Size by Type (2017-2022)
7.3 Europe Antiretroviral Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antiretroviral Drug by Region (2017-2022)
8.2 Middle East & Africa Antiretroviral Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Antiretroviral Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Antiretroviral Drug Market Forecast
10.1 Global Antiretroviral Drug Forecast by Regions (2023-2028)
10.1.1 Global Antiretroviral Drug Forecast by Regions (2023-2028)
10.1.2 Americas Antiretroviral Drug Forecast
10.1.3 APAC Antiretroviral Drug Forecast
10.1.4 Europe Antiretroviral Drug Forecast
10.1.5 Middle East & Africa Antiretroviral Drug Forecast
10.2 Americas Antiretroviral Drug Forecast by Country (2023-2028)
10.2.1 United States Antiretroviral Drug Market Forecast
10.2.2 Canada Antiretroviral Drug Market Forecast
10.2.3 Mexico Antiretroviral Drug Market Forecast
10.2.4 Brazil Antiretroviral Drug Market Forecast
10.3 APAC Antiretroviral Drug Forecast by Region (2023-2028)
10.3.1 China Antiretroviral Drug Market Forecast
10.3.2 Japan Antiretroviral Drug Market Forecast
10.3.3 Korea Antiretroviral Drug Market Forecast
10.3.4 Southeast Asia Antiretroviral Drug Market Forecast
10.3.5 India Antiretroviral Drug Market Forecast
10.3.6 Australia Antiretroviral Drug Market Forecast
10.4 Europe Antiretroviral Drug Forecast by Country (2023-2028)
10.4.1 Germany Antiretroviral Drug Market Forecast
10.4.2 France Antiretroviral Drug Market Forecast
10.4.3 UK Antiretroviral Drug Market Forecast
10.4.4 Italy Antiretroviral Drug Market Forecast
10.4.5 Russia Antiretroviral Drug Market Forecast
10.5 Middle East & Africa Antiretroviral Drug Forecast by Region (2023-2028)
10.5.1 Egypt Antiretroviral Drug Market Forecast
10.5.2 South Africa Antiretroviral Drug Market Forecast
10.5.3 Israel Antiretroviral Drug Market Forecast
10.5.4 Turkey Antiretroviral Drug Market Forecast
10.5.5 GCC Countries Antiretroviral Drug Market Forecast
10.6 Global Antiretroviral Drug Forecast by Type (2023-2028)
10.7 Global Antiretroviral Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Information
11.1.2 Gilead Sciences Antiretroviral Drug Product Offered
11.1.3 Gilead Sciences Antiretroviral Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Gilead Sciences Main Business Overview
11.1.5 Gilead Sciences Latest Developments
11.2 ViiV Healthcare
11.2.1 ViiV Healthcare Company Information
11.2.2 ViiV Healthcare Antiretroviral Drug Product Offered
11.2.3 ViiV Healthcare Antiretroviral Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 ViiV Healthcare Main Business Overview
11.2.5 ViiV Healthcare Latest Developments
11.3 Bristol-Myer Squibb
11.3.1 Bristol-Myer Squibb Company Information
11.3.2 Bristol-Myer Squibb Antiretroviral Drug Product Offered
11.3.3 Bristol-Myer Squibb Antiretroviral Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Bristol-Myer Squibb Main Business Overview
11.3.5 Bristol-Myer Squibb Latest Developments
11.4 AbbVie
11.4.1 AbbVie Company Information
11.4.2 AbbVie Antiretroviral Drug Product Offered
11.4.3 AbbVie Antiretroviral Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 AbbVie Main Business Overview
11.4.5 AbbVie Latest Developments
11.5 Boehringer-Ingelheim
11.5.1 Boehringer-Ingelheim Company Information
11.5.2 Boehringer-Ingelheim Antiretroviral Drug Product Offered
11.5.3 Boehringer-Ingelheim Antiretroviral Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Boehringer-Ingelheim Main Business Overview
11.5.5 Boehringer-Ingelheim Latest Developments
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Company Information
11.6.2 Johnson and Johnson Antiretroviral Drug Product Offered
11.6.3 Johnson and Johnson Antiretroviral Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Johnson and Johnson Main Business Overview
11.6.5 Johnson and Johnson Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Antiretroviral Drug Product Offered
11.7.3 Merck Antiretroviral Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 CIPLA
11.8.1 CIPLA Company Information
11.8.2 CIPLA Antiretroviral Drug Product Offered
11.8.3 CIPLA Antiretroviral Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 CIPLA Main Business Overview
11.8.5 CIPLA Latest Developments
12 Research Findings and Conclusion
Table 1. Antiretroviral Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Multi-Class Drugs Combination
Table 3. Major Players of NRTI
Table 4. Major Players of NNRTI
Table 5. Major Players of Protease Inhibitors
Table 6. Major Players of Other
Table 7. Antiretroviral Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Antiretroviral Drug Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Antiretroviral Drug Market Size Market Share by Type (2017-2022)
Table 10. Antiretroviral Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Antiretroviral Drug Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Antiretroviral Drug Market Size Market Share by Application (2017-2022)
Table 13. Global Antiretroviral Drug Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Antiretroviral Drug Revenue Market Share by Player (2020-2022)
Table 15. Antiretroviral Drug Key Players Head office and Products Offered
Table 16. Antiretroviral Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Antiretroviral Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Antiretroviral Drug Market Size Market Share by Regions (2017-2022)
Table 21. Americas Antiretroviral Drug Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Antiretroviral Drug Market Size Market Share by Country (2017-2022)
Table 23. Americas Antiretroviral Drug Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Antiretroviral Drug Market Size Market Share by Type (2017-2022)
Table 25. Americas Antiretroviral Drug Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Antiretroviral Drug Market Size Market Share by Application (2017-2022)
Table 27. APAC Antiretroviral Drug Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Antiretroviral Drug Market Size Market Share by Region (2017-2022)
Table 29. APAC Antiretroviral Drug Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Antiretroviral Drug Market Size Market Share by Type (2017-2022)
Table 31. APAC Antiretroviral Drug Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Antiretroviral Drug Market Size Market Share by Application (2017-2022)
Table 33. Europe Antiretroviral Drug Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Antiretroviral Drug Market Size Market Share by Country (2017-2022)
Table 35. Europe Antiretroviral Drug Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Antiretroviral Drug Market Size Market Share by Type (2017-2022)
Table 37. Europe Antiretroviral Drug Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Antiretroviral Drug Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Antiretroviral Drug Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Antiretroviral Drug Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Antiretroviral Drug Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Antiretroviral Drug Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Antiretroviral Drug Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Antiretroviral Drug Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Antiretroviral Drug
Table 46. Key Market Challenges & Risks of Antiretroviral Drug
Table 47. Key Industry Trends of Antiretroviral Drug
Table 48. Global Antiretroviral Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Antiretroviral Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Antiretroviral Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Antiretroviral Drug Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Antiretroviral Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Antiretroviral Drug Market Size Market Share Forecast by Application (2023-2028)
Table 54. Gilead Sciences Details, Company Type, Antiretroviral Drug Area Served and Its Competitors
Table 55. Gilead Sciences Antiretroviral Drug Product Offered
Table 56. Gilead Sciences Antiretroviral Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Gilead Sciences Main Business
Table 58. Gilead Sciences Latest Developments
Table 59. ViiV Healthcare Details, Company Type, Antiretroviral Drug Area Served and Its Competitors
Table 60. ViiV Healthcare Antiretroviral Drug Product Offered
Table 61. ViiV Healthcare Main Business
Table 62. ViiV Healthcare Antiretroviral Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. ViiV Healthcare Latest Developments
Table 64. Bristol-Myer Squibb Details, Company Type, Antiretroviral Drug Area Served and Its Competitors
Table 65. Bristol-Myer Squibb Antiretroviral Drug Product Offered
Table 66. Bristol-Myer Squibb Main Business
Table 67. Bristol-Myer Squibb Antiretroviral Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Bristol-Myer Squibb Latest Developments
Table 69. AbbVie Details, Company Type, Antiretroviral Drug Area Served and Its Competitors
Table 70. AbbVie Antiretroviral Drug Product Offered
Table 71. AbbVie Main Business
Table 72. AbbVie Antiretroviral Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. AbbVie Latest Developments
Table 74. Boehringer-Ingelheim Details, Company Type, Antiretroviral Drug Area Served and Its Competitors
Table 75. Boehringer-Ingelheim Antiretroviral Drug Product Offered
Table 76. Boehringer-Ingelheim Main Business
Table 77. Boehringer-Ingelheim Antiretroviral Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Boehringer-Ingelheim Latest Developments
Table 79. Johnson and Johnson Details, Company Type, Antiretroviral Drug Area Served and Its Competitors
Table 80. Johnson and Johnson Antiretroviral Drug Product Offered
Table 81. Johnson and Johnson Main Business
Table 82. Johnson and Johnson Antiretroviral Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Johnson and Johnson Latest Developments
Table 84. Merck Details, Company Type, Antiretroviral Drug Area Served and Its Competitors
Table 85. Merck Antiretroviral Drug Product Offered
Table 86. Merck Main Business
Table 87. Merck Antiretroviral Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Merck Latest Developments
Table 89. CIPLA Details, Company Type, Antiretroviral Drug Area Served and Its Competitors
Table 90. CIPLA Antiretroviral Drug Product Offered
Table 91. CIPLA Main Business
Table 92. CIPLA Antiretroviral Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. CIPLA Latest Developments
List of Figures
Figure 1. Antiretroviral Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antiretroviral Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Antiretroviral Drug Market Size Market Share by Type in 2021
Figure 7. Antiretroviral Drug in Hospital
Figure 8. Global Antiretroviral Drug Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Antiretroviral Drug in Pharmaceutical Companies
Figure 10. Global Antiretroviral Drug Market: Pharmaceutical Companies (2017-2022) & ($ Millions)
Figure 11. Antiretroviral Drug in Other
Figure 12. Global Antiretroviral Drug Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Antiretroviral Drug Market Size Market Share by Application in 2021
Figure 14. Global Antiretroviral Drug Revenue Market Share by Player in 2021
Figure 15. Global Antiretroviral Drug Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Antiretroviral Drug Market Size 2017-2022 ($ Millions)
Figure 17. APAC Antiretroviral Drug Market Size 2017-2022 ($ Millions)
Figure 18. Europe Antiretroviral Drug Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Antiretroviral Drug Market Size 2017-2022 ($ Millions)
Figure 20. Americas Antiretroviral Drug Value Market Share by Country in 2021
Figure 21. Americas Antiretroviral Drug Consumption Market Share by Type in 2021
Figure 22. Americas Antiretroviral Drug Market Size Market Share by Application in 2021
Figure 23. United States Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Antiretroviral Drug Market Size Market Share by Region in 2021
Figure 28. APAC Antiretroviral Drug Market Size Market Share by Application in 2021
Figure 29. China Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Antiretroviral Drug Market Size Market Share by Country in 2021
Figure 36. Europe Antiretroviral Drug Market Size Market Share by Type in 2021
Figure 37. Europe Antiretroviral Drug Market Size Market Share by Application in 2021
Figure 38. Germany Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Antiretroviral Drug Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Antiretroviral Drug Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Antiretroviral Drug Market Size Market Share by Application in 2021
Figure 46. Egypt Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Antiretroviral Drug Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 52. APAC Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 53. Europe Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 55. United States Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 56. Canada Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 59. China Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 60. Japan Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 61. Korea Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 63. India Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 64. Australia Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 65. Germany Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 66. France Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 67. UK Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 68. Italy Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 69. Russia Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 70. Spain Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 73. Israel Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Antiretroviral Drug Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
